A High-Risk Multiple Myeloma Group Identified By Integrative Multi-Omics Segmentation of Newly Diagnosed Patients

被引：1
|
作者：
Ortiz, Maria [1 ]
Towfic, Fadi [2 ]
Samur, Mehmet Kemal [3 ]
Flynt, Erin [4 ]
Jang, In Sock [5 ]
Wang, Kai [5 ]
Ashby, Cody [6 ]
Walker, Brian A. [6 ]
Trotter, Matthew [7 ]
Morgan, Gareth [8 ]
Munshi, Nikhil [9 ]
Thakurta, Anjan [2 ]
机构：
[1] CITRE, Res Analyt, Seville, Spain
[2] Celgene Corp, Summit, NJ USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA USA
[4] Celgene Corp, Translat Dev & Diagnost, Summit, NJ USA
[5] Celgene Corp, Res Analyt, San Diego, CA USA
[6] Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR 72205 USA
[7] CITRE, Seville, Spain
[8] Myeloma Inst Res & Therapy, Little Rock, AR USA
[9] Harvard Med Sch, Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117114
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3165
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
    M Binder
    S V Rajkumar
    R P Ketterling
    P T Greipp
    A Dispenzieri
    M Q Lacy
    M A Gertz
    F K Buadi
    S R Hayman
    Y L Hwa
    S R Zeldenrust
    J A Lust
    S J Russell
    N Leung
    P Kapoor
    R S Go
    W I Gonsalves
    R A Kyle
    S K Kumar
    Blood Cancer Journal, 2017, 7 : e600 - e600
  • [32] Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
    Binder, M.
    Rajkumar, S. V.
    Ketterling, R. P.
    Greipp, P. T.
    Dispenzieri, A.
    Lacy, M. Q.
    Gertz, M. A.
    Buadi, F. K.
    Hayman, S. R.
    Hwa, Y. L.
    Zeldenrust, S. R.
    Lust, J. A.
    Russell, S. J.
    Leung, N.
    Kapoor, P.
    Go, R. S.
    Gonsalves, W. I.
    Kyle, R. A.
    Kumar, S. K.
    BLOOD CANCER JOURNAL, 2017, 7 : e600 - e600
  • [33] Substratification of patients with newly diagnosed standard-risk multiple myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (02) : 254 - 260
  • [34] Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
    Chun-Kuang Tsai
    Chiu-Mei Yeh
    Te-Lin Hsu
    Chia-Ju Li
    Chian Tin
    Liang-Tsai Hsiao
    Yao-Chung Liu
    Hao-Yuan Wang
    Po-Shen Ko
    Po-Min Chen
    Jin-Hwang Liu
    Jyh-Pyng Gau
    Chia-Jen Liu
    Supportive Care in Cancer, 2021, 29 : 3991 - 3999
  • [35] Risk Factors for Renal Failure in Patients with Newly Diagnosed Multiple Myeloma
    Fuentes-Lacouture, Maria C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S28 - S29
  • [36] Substratification of Patients with Newly Diagnosed Standard-Risk Multiple Myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji K.
    BLOOD, 2017, 130
  • [37] Risk and Incidence of Venous Thromboembolism in Newly Diagnosed Multiple Myeloma Patients
    Nabar, Leeladhar
    Khan, Hamza
    Nair, Aditya
    Mishra, Dhyey
    Shah, Jash
    Lalwani, Devansh
    Talati, Shriraj
    Tembhare, Prashant
    Nayak, Lingaraj
    Shetty, Alok
    Rajpal, Sweta
    Chatterjee, Gaurav
    Khan, Ajmat
    Mirgh, Sumeet
    Jindal, Nishant
    Gokarn, Anant
    Punatar, Sachin
    Jain, Hasmukh
    Patkar, Nikhil
    Shetty, Dhanlaxmi
    Subramanian, Papagudi
    Gujral, Sumeet
    Bagal, Bhausaheb
    Sengar, Manju
    Khattry, Navin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S121 - S121
  • [38] Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
    Tsai, Chun-Kuang
    Yeh, Chiu-Mei
    Hsu, Te-Lin
    Li, Chia-Ju
    Tin, Chian
    Hsiao, Liang-Tsai
    Liu, Yao-Chung
    Wang, Hao-Yuan
    Ko, Po-Shen
    Chen, Po-Min
    Liu, Jin-Hwang
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3991 - 3999
  • [39] Development of a Clinical Risk Stratification for Patients with Newly Diagnosed Multiple Myeloma
    Mao, Xuehan
    Xu, Yan
    Yan, Yuting
    Liu, Jiahui
    Fan, Huishou
    Sui, Weiwei
    Deng, Shuhui
    Li, Zengjun
    Qiu, Lugui
    An, Gang
    BLOOD, 2019, 134
  • [40] Determination of the individual infection risk for newly diagnosed patients with multiple myeloma
    Kaebisch, E.
    Heck, C.
    Frentsch, M.
    Blau, I. -W
    Nogai, A.
    Bullinger, L.
    Na, I. -K
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 48 - 48
12345